MarketsandMarkets: BRIC Diabetes Drugs Market Worth US$8.7 Billion by 2015
Summary
The slowdown of the pharma market growth in developed economies has concentrated investor interest on BRIC nations, where the diabetes drug market has benefitted significantly from government initiatives for spreading patient awareness, and the subsequent increase in the uptake of novel drugs such as incretin mimetics (Eli Lilly’s Byetta) and dipeptidyl inhibitors (Merck’s Januvia and Novartis’ Galvus).The report also draws a competitive landscape, profiling the key players and the top-selling products in the diabetes drug market in BRIC.Contact: Ms. Sunita 7557 Rambler road, Suite 727, Dallas, TX 75231 Tel: +1-888-989-8004 Email: sales@marketsandmarkets.com http://www.marketsandmarkets.com ### Dallas, TX, May 29, 2010 --( PR.com )-- The report on BRIC Diabetes Drugs Market analyzes the market for oral drugs and injectables in BRIC economies over the period 2010 to 2015.MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services.M&M covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.Browse all their titles at www.marketsandmarkets.com.Contact:Ms. Sunita7557 Rambler road,Suite 727, Dallas, TX 75231Tel: +1-888-989-8004Email: sales@marketsandmarkets.comhttp://www.marketsandmarkets.com### Contact Information ReportsandReports Sunita Christ +1-888-989-8004 http://www.reportsandreports.com/market-reports/application-stores-game-plan-for-network-operators/ 7557 Rambler road, Suite 727, Dallas, TX 75231 Click here to view the list of recent Press Releases from marketsandmarkets Promote Your Business Press Release Pricing Email this page to a friend